Discovering a new role for a breast cancer gene

January 18, 2013

(Medical Xpress)—Researchers at the School of Biosciences have identified an unexpected role for a tumour-associated gene in breast cancer.

Previous studies using tumour cells grown in the laboratory had suggested that the gene, Bcl3, regulated tumour growth.  However when the research team, led by Dr Richard Clarkson, looked at the effect of suppressing this gene in mammary tumours inside the body, they found that this had no effect on tumour growth, but instead prevented the tumours from spreading to other organs.  This is significant because tumour spread (metastasis) is the major cause of death in .

"We have identified an unexpected role for this gene in living tissues, which we would not have predicted from studies of grown outside of the body." Dr Clarkson explained.  "This approach has also revealed that suppressing this gene is not harmful to normal tissues, which makes Bcl3 a promising for breast cancer".  

The results of this study, which have been reported in the leading cancer journal Cancer Research, has led the research team to develop novel pharmacological inhibitors of Bcl3.  These inhibitors are currently undergoing pre-clinical tests to evaluate their potential as anti- that could prevent the spread of cancer, in patients with aggressive forms of breast disease.

More information: www.ncbi.nlm.nih.gov/pubmed?term=Clarkson%20wakefield

Related Stories

Silencing a deadly conversation in breast cancer

June 2, 2011

While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning ...

Treatment of common virus can reduce tumour growth

September 27, 2011

Researchers at Karolinska Institutet in Sweden have demonstrated for the first time that it is possible to inhibit the growth of brain tumours by treating the common Cytomegalovirus (CMV). The virus, which is found in a wide ...

A new indicator for breast cancer relapse identified

June 19, 2012

Researchers at the IMIM (Institut de Recerca Hospital del Mar) have proven that the absence of the 14-3-3 protein sigma in breast cancer cells is directly associated with these cells' capacity to activate the signalling of ...

Recommended for you

New treatment options for a fatal leukemia

July 27, 2015

In industrialized countries like in Europe, acute lymphoblastic leukemia is the most common form of cancer in children. An international research consortium lead by pediatric oncologists from the Universities of Zurich and ...

Exciting results from cancer immunoagent study

July 20, 2015

(Medical Xpress)—Cancer therapies have improved incrementally over the years, but cancer treatment largely remains analogous to forest fire suppression, in which the spread of fire is contained with deliberate controlled ...

Modified DNA building blocks are cancer's Achilles heel

July 22, 2015

In studying how cells recycle the building blocks of DNA, Ludwig Cancer Research scientists have discovered a potential therapeutic strategy for cancer. They found that normal cells have highly selective mechanisms to ensure ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.